Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v25-EN Version v24-FR
Language English French
Date Updated 2024-05-24 2024-04-18
Drug Identification Number 02459817 02459817
Brand name AURO-PERINDOPRIL AURO-PERINDOPRIL
Common or Proper name AURO-PERINDOPRIL AURO-PERINDOPRIL
Company Name AURO PHARMA INC AURO PHARMA INC
Ingredients PERINDOPRIL ERBUMINE PERINDOPRIL ERBUMINE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 3x10 Blst 3x10 Blst
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date 2023-09-15 2023-09-15
Actual start date 2023-11-15 2023-11-15
Estimated end date 2024-07-03 2024-07-03
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments